申请人:Sterling Drug Inc.
公开号:US03960945A1
公开(公告)日:1976-06-01
3-R-3-(Ac.sub.2 NH)-9-R'-9-(Ac.sub.1 NH)-1,5-dioxaspiro[5.5]undecane (I), where R and R' are each hydrogen or lower-alkyl, Ac.sub.1 is lower-alkanoyl or 4-Q.sub.1 -benzoyl and Ac.sub.2 is 4-Q.sub.2 -benzoyl where Q.sub.1 and Q.sub.2 each is lower-alkoxy or polyhalo-lower-alkoxy, are antifertility agents. The compounds are prepared by di-acylating 3-R-9-R'-1,5-dioxaspiro[5.5]undecan-3,9-diamine (II) or mono-acylating 9-(Ac.sub.1 NH)-3-R-9-R'-1,5-dioxaspiro[5.5]undecan-3-amine (IV). IV and II are prepared by oxidizing 4-(Ac.sub.1 NH)-4-R'-cyclohexanol (VI) to produce 4-(Ac.sub.1 NH)-4-R'-cyclohexanone (VII), reacting VII with 2-NO.sub.2 -2-R-1,3-propanediol to produce 3-R-3-NO.sub.2 -9-(Ac.sub.1 NH)-9-R'-1,5-dioxaspiro[5.5]undecane (VIII), reducing VIII to produce the corresponding 3-amine (IV) and hydrolyzing IV to the corresponding 3,9-diamine (II). Methods of preparing VI are shown.
3-R-3-(Ac.sub.2 NH)-9-R'-9-(Ac.sub.1 NH)-1,5-二氧杂螺[5.5]十一烷(I),其中R和R'分别是氢或较低的烷基,Ac.sub.1是较低的烷酰基或4-Q.sub.1-苯甲酰基,Ac.sub.2是4-Q.sub.2-苯甲酰基,其中Q.sub.1和Q.sub.2各自是较低的烷氧基或多卤代较低的烷氧基,是抗生育剂。这些化合物是通过对3-R-9-R'-1,5-二氧杂螺[5.5]十一烷-3,9-二胺(II)进行双酰化或对9-(Ac.sub.1 NH)-3-R-9-R'-1,5-二氧杂螺[5.5]十一烷-3-胺(IV)进行单酰化来制备的。IV和II是通过将4-(Ac.sub.1 NH)-4-R'-环己醇(VI)氧化制备4-(Ac.sub.1 NH)-4-R'-环己酮(VII),将VII与2-NO.sub.2-2-R-1,3-丙二醇反应制备3-R-3-NO.sub.2-9-(Ac.sub.1 NH)-9-R'-1,5-二氧杂螺[5.5]十一烷(VIII),将VIII还原制备相应的3-胺(IV),并将IV水解制备相应的3,9-二胺(II)。显示了制备VI的方法。